Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures

Please see the October 2013 FDA Drug Safety Communication regarding Potiga and skin discoloration/retinal abnormalities

You'll see patients on Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures.

It has a unique mechanism...and some unusual side effects.

In fact, the manufacturer is required to have a risk management program to alert prescribers, pharmacists, and patients to the risk of urinary retention.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote